| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Dec―24 |
Key risk factors for in-hospital mortality following valve surgery in patients with prior COVID-19 infection |
D. M. Kosovan, O. A. Krykunov, V. V. Lazoryshynets, K. V. Rudenko |
| 2 |
[GO] |
2025―Dec―24 |
Coronavirus disease 2019 (COVID-19) in pregnancy: pathomorphological ultrastructural changes of the placenta |
T. V. Savchuk, I. V. Leshchenko, V. V. Vaslovych, O. H. Chernenko, T. A. Malysheva |
| 3 |
[GO] |
2025―Oct―16 |
Pathomorphological brain changes due to coronavirus disease 2019 (COVID-19) |
L. I. Volos, H. L. Stoliar |
| 4 |
[GO] |
2025―Jan―10 |
Hormonal-metabolic markers and their relationships in patients with coronary heart disease after suffering from the COVID-19 coronavirus disease |
S. M. Manuilov, N. S. Mykhailovska |
| 5 |
[GO] |
2025―Jan―10 |
Features of liver damage in patients with coronavirus disease (COVID-19) with pneumonia in relation to indicators of inflammation taking into account oxygen dependence |
O. V. Riabokon, I. O. Kuliesh |
| 6 |
[GO] |
2025―Jan―10 |
Influence of anticoagulant therapy on immune and inflammatory response in patients with community-acquired pneumonia associated with coronavirus infection |
S. S. Avhaitis |
| 7 |
[GO] |
2024―Sep―05 |
Clinical-pathogenetic and prognostic value of the nitrotyrosine level in the blood serum of patients with coronavirus disease (COVID-19) with pneumonia |
O. V. Riabokon, I. O. Kuliesh, I. F. Bielenichev, Yu. Yu. Riabokon |
| 8 |
[GO] |
2023―Dec―27 |
The role of clinical and immunological parameters in predicting the effectiveness of additional immunotropic therapy in oxygen-dependent patients with COVID-19 coronavirus disease |
O. V. Riabokon, V. V. Cherkaskyi, Yu. Yu. Riabokon, A. V. Vynokurova |
| 9 |
[GO] |
2023―Oct―20 |
Clinical and prognostic value of parameters of cytokine regulation in oxygen-dependent patients with the coronavirus disease COVID-19 |
O. V. Riabokon, V. V. Cherkaskyi, Yu. Yu. Riabokon, R. O. Shcherbyna |
| 10 |
[GO] |
2023―Jun―09 |
The clinical and prognostic role of changes in parameters of the hemostasis system and C-reactive protein in the development of thrombotic complications in oxygen-dependent patients with coronavirus disease (COVID-19) |
V. V. Cherkaskyi, O. V. Riabokon, Yu. Yu. Riabokon |
| 11 |
[GO] |
2023―Mar―03 |
Clinical cases of extrapulmonary manifestations in patients with coronavirus disease (COVID-19) |
O. V. Riabokon, К. А. Pak, О. О. Furyk, V. V. Cherkaskyi |
| 12 |
[GO] |
2023―Mar―03 |
Prognostic role of demographic indicators and Charlson comorbidity index in oxygen-dependent patients with coronavirus disease (COVID-19) |
V. V. Cherkaskyi, O. V. Riabokon, Yu. Yu. Riabokon |
| 13 |
[GO] |
2023―Mar―03 |
Multisystem inflammatory syndrome, probably associated with SARS-CoV-2, complicated by thrombus in the right atrium, in a child |
O. V. Usachova, O. V. Konakova, Ye. A. Silina, N. V. Vorobiova |
| 14 |
[GO] |
2022―Jul―22 |
Clinical experience with tocilizumab in the treatment of pregnant woman with severe COVID-19 |
O. V. Riabokon, I. O. Kuliesh, O. O. Furyk, T. B. Matvieieva, K. V. Kalashnyk |
| 15 |
[GO] |
2022―Jan―10 |
Clinical and pathomorphological analysis of deaths from COVID-19 in 2020 |
O. V. Riabokon, L. M. Tumanska, V. V. Cherkaskyi, Yu. Yu. Riabokon |
| 16 |
[GO] |
2022―Jan―10 |
COVID-19 pandemic and quarantine-related health disorders in combatants of Ukraine |
N. V. Danilevska |
| 17 |
[GO] |
2022―Jan―10 |
Morphological features of changes in peripheral olfactory structures in SARS-COV-2 coronavirus infection |
I. S. Shponka, V. I. Popovych, О. М. Usova, O. O. Bondarenko, Yu. V. Haman, H. Z. Shchuruk |
| 18 |
[GO] |
2021―Oct―08 |
Pathomorphological changes of the placenta in coronavirus disease (COVID 19) |
T. V. Savchuk, S. H. Gychka, I. V. Leshchenko |
| 19 |
[GO] |
2020―Oct―07 |
Pathophysiological mechanisms of coronavirus disease (COVID-19) progression and fatal complications in patients with diabetes |
T. O. Briukhanova, A. L. Zagayko, D. V. Lytkin |
| 20 |
[GO] |
2020―Jun―03 |
Pathophysiological substantiation of the effectiveness of quercetine use in coronavirus disease (COVID-19) therapy |
I. A. Zupanets, S. K. Shebeko, N. P. Bezugla, I. A. Otrishko |
